Trial reportCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025
Sex-Specific Outcomes after a Negative Colonoscopy in the Finnish Randomized Health Service Study during 2004 to 2016.
Trial report in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn the randomized colorectal cancer screening trial carried out in Finland between 2004 and 2016, participants were referred to colonoscopy based on the results of the guaiac fecal occult blood test. We assessed sex-specific colorectal cancer incidence and standardized incidence ratios (SIR) after a positive guaiac fecal occult blood test and a negative colonoscopy.
methodsWe used data from a Finnish randomized colorectal cancer screening trial with colorectal cancer diagnoses from the Finnish Cancer Registry. We compared the colorectal cancer incidence of the colonoscopy-negative screening population with the expected incidence based on the control population in three follow-up periods ([0.5, 2), [2, 6), and more than 6 years) by calculating age- and sex-specific SIRs.
resultsIn men, the SIR was 0.28 [95% confidence interval (CI), 0.03-1.01] during the [0.5, 2) years of follow-up. During the [2, 6) years of follow-up, it was 0.51 (95% CI, 0.26-0.92), and during the 6 or more years of follow-up, it was 0.33 (95% CI, 0.12-0.72). In women, the SIRs were 1.63 (0.66-3.36), 1.15 (0.65-1.90), and 0.83 (0.40-1.52), respectively.
conclusionsUnlike men, the negative colonoscopy was not associated with a lower incidence of colorectal cancer in any of the follow-up periods in women. This suggests that the guidelines for intervals between negative colonoscopy and the time of the next screening invitation might need to be considered separately based on sex. IMPACT: This study emphasizes the difference in the protective effect of negative colonoscopy between men and women. More research is needed, especially in the context of new screening methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.